Syntegra Private Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
1,453
+132
+10% +$135K 0.14% 46
2026
Q1
$1.22M Sell
1,321
-92
-7% -$93.3K 0.12% 57
2025
Q4
$1.52M Buy
1,413
+44
+3% +$42.1K 0.14% 49
2025
Q3
$1.04M Buy
1,369
+58
+4% +$43.2K 0.1% 63
2025
Q2
$1.02M Buy
1,311
+279
+27% +$217K 0.1% 63
2025
Q1
$853K Buy
1,032
+629
+156% +$523K 0.1% 57
2024
Q4
$311K Buy
+403
New +$334K 0.04% 117

Other funds holding LLY

Syntegra Private Wealth Group's LLY Position: Q2 2026 in Review

Syntegra Private Wealth Group increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $135K and bringing the position to 1,453 shares worth $1.74M. The position accounts for 0.14% of the portfolio, ranked #46.

Syntegra Private Wealth Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,984 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Syntegra Private Wealth Group held 1,453 shares of Eli Lilly worth $1.74M as of Q2 2026.
  • Syntegra Private Wealth Group bought 132 Eli Lilly shares in Q2 2026, an estimated $135K.
  • Eli Lilly made up 0.14% of Syntegra Private Wealth Group's portfolio in Q2 2026, its #46 holding.
  • Syntegra Private Wealth Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,984 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Syntegra Private Wealth Group's 13F filing for Q2 2026, filed 15 Jul 2026.